BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1107261 HOUSTON, TX

Position in ACRS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$396,850

-$840,721 QoQ

Shares Held

75,019

-77.3% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#75

of 149 holders

Holding Since

Jun 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. ACRS ranks #47 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GLUE	Monte Rosa Therapeutics, Inc.	552,566	$13,372,097
2	INVA	Innoviva, Inc.	350,253	$7,954,245
3	PBYI	Puma Biotechnology, Inc.	791,616	$6,420,005
4	RIGL	Rigel Pharmaceuticals Inc	124,184	$4,858,078
5	EXEL	Exelixis, Inc.	66,100	$3,596,501
6	CRMD	CorMedix Inc.	434,132	$3,407,936
7	KROS	Keros Therapeutics, Inc.	265,017	$2,835,681
8	PTCT	Ptc Therapeutics, Inc.	22,000	$1,794,540

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$396,850	75,019	-77.3%	Shares	Sole	2026-08-14
2026-03-31	$1,237,571	330,019	0.0%	Shares	Sole	2026-05-15
2025-12-31	$993,357	330,019	-16.1%	Shares	Sole	2026-02-17
2025-09-30	$747,306	393,319	-11.3%	Shares	Sole	2025-11-14
2025-06-30	$629,512	443,319	+53.5%	Shares	Sole	2025-08-14
2025-03-31	$441,740	288,719	+2.7%	Shares	Sole	2025-05-15
2024-12-31	$697,175	281,119	+41.2%	Shares	Sole	2025-02-14
2024-09-30	$228,986	199,119	+32.1%	Shares	Sole	2024-11-14
2024-06-30	$165,770	150,700	+11.6%	Shares	Sole	2024-08-14
2021-06-30	$2,370,600	135,000	-37.0%	Shares	Sole	2021-08-16
2021-03-31	$5,400,360	214,300	-10.5%	Shares	Sole	2021-05-17
2020-12-31	$1,548,918	239,400	-12.8%	Shares	Sole	2021-02-16
2020-09-30	$705,208	274,400	0.0%	Shares	Sole	2020-11-16
2020-06-30	$444,528	274,400	—	Shares	Sole	2020-08-31
No filing history on record for this holder in this stock.